Junipero Therapeutics, Inc.
Durham, NC
- UEI
- H96WZKBAWJ48
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2205 Edwin Ave, Durham, NC 27705, USA
- Website
- juniperotx.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase i: epigenome editing by induced proximity using oligonulcleotide-conjugates | National Science Foundation | $305,000 |
Quick answers
Is Junipero Therapeutics, Inc. registered in SAM.gov?
Yes. Junipero Therapeutics, Inc.'s SAM.gov registration is active through September 27, 2027.
What is Junipero Therapeutics, Inc.'s most recent federal award?
Junipero Therapeutics, Inc.'s most recent federal grant award is Sbir phase i: epigenome editing by induced proximity using oligonulcleotide-conjugates (2451259), from National Science Foundation, on April 15, 2025.
On GovTribe
See Junipero Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors